US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 1.7902
  • +0.1802+11.19%
Trading Mar 17 13:08 ET
16.52MMarket Cap-0.28P/E (TTM)

About SAB Biotherapeutics Company

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.

Company Profile

SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address777 West 41st Street,Suite 401
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33140
Phone1-605-679-6980
Websitehttp://www.sab.bio

Company Executives

  • Name
  • Position
  • Salary
  • Samuel J. Reich
  • Chief Executive Officer and Director
  • 565.80K
  • Lucy To
  • Chief Financial Officer
  • --
  • Christoph Lawrence Bausch
  • Chief Operating Officer
  • 549.32K
  • Dr. Alexandra Kropotova, M.D.
  • Chief Medical Officer and Executive Vice President
  • 921.58K
  • Mark William Conley, C.P.A.
  • Vice President, Finance
  • --
  • David Link, M.B.A.
  • Vice Chairman of the Board
  • 25.00K
  • Dr. Eddie J. Sullivan, PhD
  • Director and President
  • 202.60K
  • Dr. Jay S. Skyler,M.D.,M.A.C.P.
  • Director
  • --
  • Erick J. Lucera, C.F.A.
  • Independent Director
  • 26.93K
  • Admiral Scott Giberson, (Ret.)
  • Independent Director
  • 25.00K
  • Helen Katherine Ellias
  • Independent Director
  • --
  • Jeffrey G. Spragens
  • Independent Director
  • 25.00K
  • Andrew D. Moin
  • Independent Director
  • --
  • Dr. William J. Polvino, M.D.
  • Independent Director
  • 25.00K
  • Christine Hamilton, M.B.A.
  • Independent Director
  • 25.00K

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Petroleo Brasileiro SA Petrobras
PBR
13.965
Oracle
ORCL
153.940
Ecopetrol
EC
10.441
4
Vale SA
VALE
10.065
5
Coinbase
COIN
187.610
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!